The U.S. Food and Drug Administration (FDA), the US governmental authority responsible for regulating foods and medical ...

Zyn has taken the U.S. by storm. The nicotine pouch brand's boom came at an opportune time for parent company Philip Morris ...

Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the marketing of 20 of the tobacco company’s Zyn nicotine pouches.

In a statement, the FDA said it has authorized the marketing and sale of Philip Morris International’s Zyn nicotine pouches.

Investing.com -- Shares of Philip Morris International Inc. (NYSE:PM) rose 1% following the U.S. Food and Drug Administration's (FDA) authorization of 20 ZYN nicotine pouch products for marketing.

Philip Morris International Inc. (PMI) (NYSE: PM) will host a live audio webcast at on Thursday, February 6, 2025, at 9:00 a ...

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40, late Thursday ...

authorizing Philip Morris International’s Zyn to help adult smokers cut back or quit cigarettes. The Food and Drug Administration OK’d 10 Zyn flavors, including coffee, mint and menthol.

On January 16, Philip Morris International Inc. (NYSE:PM) announced that the US Food and Drug Administration (FDA) has authorized all ZYN nicotine pouches currently marketed by Swedish Match.

Philip Morris International said on Tuesday it ... maker Altria said on Wednesday it had sent data to the U.S. Food and Drug Administration on growth in illegal nicotine pouches, saying it echoed ...

These items have become popular in c-stores as traditional tobacco sales plunge, and their approval sets the stage for continued growth.

Philip Morris International shares edged up slightly after the Food and Drug Administration authorized marketing for 20 Zyn nicotine-pouch products. The stock rose about 1%, to $119.40 ...